The healthcare sector is witnessing an escalating demand for timely, pertinent, and high-quality evidence that extends beyond conventional sources. From extensive healthcare transaction data to personal wearables and environmental trends, these demands present opportunities for Health Technology Assessment (HTA) to innovate and collaborate, positioning itself at the forefront of addressing both technological and non-technological changes in healthcare. 

Next Generation (NextGen) Evidence embodies a transformative shift in how we generate, analyze, interpret, and utilize evidence in HTA. It embraces a spectrum of solutions, from high-tech to low-tech, reflecting the evolving global perspectives and capacities needed to meet diverse healthcare demands. This type of evidence expands the scope of HTA to encompass greater dimensions of health technology impact, innovative trial designs, non-traditional data sources, equity considerations, environmental factors, advanced artificial intelligence (AI) tools, and adaptive HTA methods.

Join us in Buenos Aires, Argentina, to delve into these topics and contribute to the ongoing conversations shaping the future of HTA.